{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05651230",
            "orgStudyIdInfo": {
                "id": "STUDY00003693"
            },
            "organization": {
                "fullName": "University of Texas at Austin",
                "class": "OTHER"
            },
            "briefTitle": "Seaweed-derived Rhamnan Sulfate and Vascular Function",
            "officialTitle": "Seaweed-derived Rhamnan Sulfate and Vascular Function",
            "therapeuticArea": [
                "Other"
            ],
            "study": "seaweed-derived-rhamnan-sulfate-and-vascular-function"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-04-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-05-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-05-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-11-28",
            "studyFirstSubmitQcDate": "2022-12-06",
            "studyFirstPostDateStruct": {
                "date": "2022-12-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-05-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-05-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Texas at Austin",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Konan Chemical Manufacturing",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease."
        },
        "conditionsModule": {
            "conditions": [
                "Cardiovascular Diseases"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Rhamnan sulfate",
                    "type": "EXPERIMENTAL",
                    "description": "The subjects will take rhamnan sulfate (Rhamnox100, Konan Chemical Manufacturing Co. LTD, Mie, Japan: 540 mg/day) orally three time daily at each meal time.",
                    "interventionNames": [
                        "Dietary Supplement: Rhamnan sulfate"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "The subjects will take placebo (Konan Chemical Manufacturing Co. LTD, Mie, Japan: 540 mg/day) orally three time daily at each meal time.",
                    "interventionNames": [
                        "Dietary Supplement: Rhamnan sulfate"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Rhamnan sulfate",
                    "description": "A randomized, placebo-controlled, double-blind crossover dietary supplement intervention consisting of 3 weeks each of rhamnan sulfate (Rhamnox100, Konan Chemical Manufacturing Co. LTD, Mie, Japan: 540 mg/day) or placebo with 2 weeks of washout between the interventions will be conducted. Dietary supplements (rhamnan sulfate) will be taken orally three time daily at each meal time. Rhamnan sulfate is a polysaccharide (carbohydrate) extracted from seaweeds and can be considered nutrition supplement. As each pill contains 90 mg of rhamnan sulfate or placebo, subjects will be taking 2 pills before or during each meal.",
                    "armGroupLabels": [
                        "Placebo",
                        "Rhamnan sulfate"
                    ],
                    "otherNames": [
                        "Rhamnox100"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Vascular function",
                    "description": "Endothelium-dependent vasodilation as assessed by flow-mediated dilation",
                    "timeFrame": "Before the 3-week intervention"
                },
                {
                    "measure": "Vascular function",
                    "description": "Endothelium-dependent vasodilation as assessed by flow-mediated dilation",
                    "timeFrame": "After the 3-week intervention"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* at least one risk factor for cardiovascular disease (e.g., dyslipidemia, hypertension, obesity, impaired fasting glucose)\n* a BMI of \\<40 kg/m2\n\nExclusion Criteria:\n\n* gastrointestinal disorders and/or renal disease\n* pregnancy or lactation\n* strenuous physical activity (\\>3 times/week)\n* alcohol abuse",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "35 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "Cardiovascular Aging Research Lab at UT Austin",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78712",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hirofumi Tanaka, PhD",
                            "role": "CONTACT",
                            "phone": "512-232-4801",
                            "email": "htanaka@austin.utexas.edu"
                        },
                        {
                            "name": "Hirofumi Tanaka, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED",
            "description": "Available upon reasonable request after the research findings are published."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ]
        }
    },
    "hasResults": false
}